|
1MKE
Structure of the N-WASP EVH1 Domain-WIP complex
提交 2002-08-29
|
构建体不同
聚集状态不同
实验环境不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
461–485(25 aa)
片段:WIP peptide and N-WASP EVH1 domain
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 7;303 K;离子强度(mmCIF原始值)20 mM NaCl;压力 ambient
NMR样品组成
U-15N protein
20 mM PO4 buffer
1 mM dithiothreitol | 90% H2O/10% D2O
NMR样品组成
U-13C/15N protein
20 mM PO4 buffer
1 mM dithiothreitol | 90% H2O/10% D2O
|
分辨率未提供
|
|
2A41
Ternary complex of the WH2 Domain of WIP with Actin-DNAse I
提交 2005-06-27
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 C
29–60(32 aa)
片段:first WH2 domain
|
未记录
|
CA CALCIUM ION × 2
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
FMT FORMIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;sodium formate, PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.60 Å
R-free 0.219
|
|
2IFS
Structure of the N-WASP EVH1 domain in complex with an extended WIP peptide
提交 2006-09-21
|
构建体不同
聚集状态不同
实验环境不同
|
Assembly 1
信息不足
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
451–485(35 aa)
片段:WIP peptide (residues 451-485) and N-WASP EVH1 domain (Residues 26-147)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 7;303 K;离子强度(mmCIF原始值)0.044 mM;压力 1
NMR样品组成
1.0 mM U-15N/13C protein, 20 mM sodium phosphate, 1 mM Dithiothreitol, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
分辨率未提供
|
|
9EZO
Canonical class 2 structure of the human cortactin SH3 domain in complex with WIP-derived peptide
提交 2024-04-13
|
实验环境不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
165–183(19 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 6.6;298 K;离子强度(mmCIF原始值)0.055;压力 1
NMR样品组成
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR样品组成
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR样品组成
0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR样品组成
0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 100% D2O | 100% D2O
NMR样品组成
0.22 mM [U-99% 13C; U-99% 15N] Human cortactin SH3 domain (494-550), 1.1 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 1 mM dithiothreitol, 100% D2O | 100% D2O
|
分辨率未提供
|
|
9EZP
Non-canonical structure of the human cortactin SH3 domain in complex with WIP-derived peptide
提交 2024-04-13
|
当前字段一致
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 B
165–183(19 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 6.6;298 K;离子强度(mmCIF原始值)0.055;压力 1
NMR样品组成
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR样品组成
0.7 mM Human WIP (165-183), 20 mM potassium phosphate, 20 mM sodium chloride, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR样品组成
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 93% H2O/7% D2O | 93% H2O/7% D2O
NMR样品组成
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 15N; U-80% 2H] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR样品组成
1.1 mM Human WIP (165-183), 0.22 mM [U-99% 13C; U-99% 15N] Human cortactin SH3 domain (494-550), 20 mM potassium phosphate, 20 mM sodium chloride, 1 mM dithiothreitol, 0.02 % sodium azide, 100% D2O | 100% D2O
|
分辨率未提供
|